Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print


A guest editorial in The Cancer Letter stated that “work has halted on ECOG-ACRIN Cancer Research Group’s landmark Tomosynthesis Mammographic Imaging Screening Trial.” (The Cancer Letter, April 10, 2020) The TMIST breast cancer screening trial is not suspended. TMIST formally remains an ongoing study under the NCI and Cancer Trials Support Unit. Active participation at this time is at the discretion of individual sites. Sites are making critical local operational decisions to help manage any potential influx of COVID-19 patients and maintain the safety of patients and staff. As a result, some sites have suspended non-urgent health care services, such as screening mammography, and research operations.


A COVID-19 Update on April 24 reported that The Association of American Cancer Institutes annual meeting has moved to a virtual format (The Cancer Letter, April 24, 2020). The Association of American Cancer Institutes’ Clinical Research Innovation (CRI) program has moved its July 7-8 annual meeting to a virtual format. The AACI annual meeting, which takes place Oct. 11-13 in Kansas City, MO, is still scheduled as an in-person meeting at this time.

Table of Contents


John A. Ellerton, the principal investigator of the Nevada Cancer Research Foundation NCI Community Oncology Research Program, has won the 2021 Harry Hynes Award. The award is given annually to NCORP PIs for outstanding contribution to clinical trials and community research. In 1983, Ellerton’s group, then called the Southern Nevada Research Foundation, was among the...

From 1992 to 2008, Ellen Stovall was the president and CEO of NCCS, the oldest survivor-led organization advocating for quality cancer care for all Americans. This video, filmed and produced in 2008, features interviews from NCCS co-founders Dr. Patti Ganz and Dr. Fitzhugh Mullan, Dr. Julia Rowland, Dr. Zeke Emanuel, the late General H. Norman Schwarzkopf, and others.